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Abstract
Background: A strong need exists for a validated tool that clearly defines peer review report quality in biomedical
research, as it will allow evaluating interventions aimed at improving the peer review process in well-performed
trials. We aim to identify and describe existing tools for assessing the quality of peer review reports in biomedical
research.
Methods: We conducted a methodological systematic review by searching PubMed, EMBASE (via Ovid) and The
Cochrane Methodology Register (via The Cochrane Library) as well as Google® for all reports in English describing a
tool for assessing the quality of a peer review report in biomedical research. Data extraction was performed in
duplicate using a standardized data extraction form. We extracted information on the structure, development and
validation of each tool. We also identified quality components across tools using a systematic multi-step approach
and we investigated quality domain similarities among tools by performing hierarchical, complete-linkage clustering
analysis.
Results: We identified a total number of 24 tools: 23 scales and 1 checklist. Six tools consisted of a single item and
18 had several items ranging from 4 to 26. None of the tools reported a definition of ‘quality’. Only 1 tool described
the scale development and 10 provided measures of validity and reliability. Five tools were used as an outcome in
a randomized controlled trial (RCT). Moreover, we classified the quality components of the 18 tools with more than
one item into 9 main quality domains and 11 subdomains. The tools contained from two to seven quality domains.
Some domains and subdomains were considered in most tools such as the detailed/thorough (11/18) nature of
reviewer’s comments. Others were rarely considered, such as whether or not the reviewer made comments on the
statistical methods (1/18).
Conclusion: Several tools are available to assess the quality of peer review reports; however, the development and
validation process is questionable and the concepts evaluated by these tools vary widely. The results from this
study and from further investigations will inform the development of a new tool for assessing the quality of peer
review reports in biomedical research.
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Background
The use of editorial peer review originates in the eighteenth
century [1]. It is a longstanding and established process that
generally aims to provide a fair decision-making mecha-
nism and improve the quality of a submitted manuscript
[2]. Despite the long history and application of the peer
review system, its efficacy is still a matter of controversy
[3–7]. About 30 years after the first international Peer Re-
view Congress, there are still ‘scarcely any bars to eventual
publication. There seems to be no study too fragmented,
no hypothesis too trivial [...] for a paper to end up in print’
(Drummond Rennie, chair of the advisory board) [8].
Recent evidence suggests that many current editors
and peer reviewers in biomedical journals still lack the
appropriate competencies [9]. In particular, it has been
shown that peer reviewers rarely receive formal training
[3]. Moreover, their capacity to detect errors [10, 11],
identify deficiencies in reporting [12] and spin [13] has
been found lacking.
Some systematic reviews have been performed to esti-
mate the effect of interventions aimed at improving the
peer review process [2, 14, 15]. These studies showed
that there is still a lack of evidence supporting the use of
interventions to improve the quality of the peer review
process. Furthermore, Bruce and colleagues highlighted
the urgent need to clarify outcomes, such as peer review
report quality, that should be used in randomized con-
trolled trials evaluating these interventions [15].
A validated tool that clearly defines peer review report
quality in biomedical research is greatly needed. This
will allow researchers to have a structured instrument to
evaluate the impact of interventions aimed at improving
the peer review process in well-performed trials. Such a
tool could also be regularly used by editors to evaluate
the work of reviewers.
Herein, as starting point for the development of a new
tool, we identify and describe existing tools that assess the
quality of peer review reports in biomedical research.
Methods
Study design
We conducted a methodological systematic review and
followed the standard Preferred Reporting Items for Sys-
tematic Review and Meta-Analysis (PRISMA) guidelines
[16]. The quality of peer review reports is an outcome
that in the long term is related to clinical relevance and
patient care. However, the protocol was not registered in
PROSPERO, as this review does not contain direct
health-related outcomes [17].
Information sources and search strategy
We searched PubMed, EMBASE (via Ovid) and The
Cochrane Methodology Register (via The Cochrane
Library) from their inception to October 27, 2017 as well
as Google® (search date: October 20, 2017) for all reports
describing a tool to assess the quality of a peer review
report in biomedical research. Search strategies were
refined in collaboration with an expert methodologist
(IS) and are presented in the Additional file 1. We
hand-searched the citation lists of included papers and
consulted a senior editor with expertise in editorial
policies and peer review processes to further identify
relevant reports.
Eligibility criteria
We included all reports describing a tool to assess the
quality of a peer review report. Sanderson and colleagues
defined a tool as ‘any structured instrument aimed at
aiding the user to assess the quality [...]’ [18]. Building
on this definition, we defined a quality tool as any struc-
tured or unstructured instrument assisting the user to
assess the quality of peer review report (for definitions
see Table 1). We restricted inclusion to the English
language.
Study selection
We exported the references retrieved from the search
into the reference manager Endnote X7 (Clarivate Ana-
lytics, Philadelphia, United States), which was subse-
quently used to remove duplicates. We reviewed all
records manually to verify and remove duplicates that
had not been previously detected. A reviewer (CS)
screened all titles and abstracts of the retrieved citations.
A second reviewer (JAG) carried out quality control on
a 25% random sample obtained using the statistical soft-
ware R 3.3.3 [19]. We obtained and independently exam-
ined the full-text copies of potentially eligible reports for
further assessment. In the case of disagreement, consen-
sus was determined by a discussion or by involving a
third reviewer (DH). We reported the result of this
Table 1 Definition of terms used in the present study
Structured quality tool: scale or checklist including more than one item
aimed at guiding the user to assess the overall quality of a peer review
report.
Unstructured quality tool: scale or checklist including only one item
inquiring the overall quality of a peer review report.
Items: elements of a scale or checklist representing a component of
peer review report quality. Items in a scale could or could not have an
attached numerical score. If there is no attached score, these items
provide the evaluator with a guidance to assess the overall quality of a
peer review report.
Overall quality score in a scale is measured as:
• Sum of scores: score obtained by summing all scores for each item
present in a scale.
• Mean of scores: score obtained by dividing the sum of scores for each
item with the total number of items included in the tool.
• Single score: score obtained in those scales based on a single item.
• Summary score: score obtained in those scales with more than one
item deriving from a question inquiring the overall quality of peer
review report.
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process through a PRISMA flowchart [16]. When several
tools were reported in the same article, they were included
as separate tools. When a tool was reported in more than
one article, we extracted data from all related reports.
Data extraction
General characteristics of tools
We designed a data extraction form using Google® Docs
and extracted the general characteristics of the tools. We
determined whether the tool was scale or checklist. We
defined a tool as a scale when it included a numeric or
nominal overall quality score while we considered it as a
checklist when an overall quality score was not present.
We recorded the total number of items (for definitions
see Table 1). For scales with more than 1 item we
extracted how items were weighted, how the overall
score was calculated, and the scoring range. Moreover,
we checked whether the scoring instructions were
adequately defined, partially defined, or not defined
according to the subjective judgement of two reviewers
(CS and JAG) (an example of the definition for scoring
instructions is shown in Table 2). Finally, we extracted
all information related to the development, validation,
and assessment of the tool’s reliability and if the concept
of quality was defined.
Two reviewers (CS and JAG) piloted and refined the
data extraction form on a random 5% sample of
extracted articles. Full data extraction was conducted by
two reviewers (CS and JAG) working independently for
all included articles. In the case of disagreement, consen-
sus was obtained by discussion or by involving a third
reviewer (DH). Authors of the reports were contacted in
cases where we needed further clarification of the tool.
Quality components of the peer review report considered in
the tools
We followed the systematic multi-step approach recently
described by Gentles [20], which is based on a constant
comparative method of analysis developed within the
Grounded Theory approach [21]. Initially, a researcher
(CS) extracted all items included in the tools and for
each item identified a ‘key concept’ representing a qua-
lity component of peer review reports. Next, two
researchers (CS and DH) organized the key concepts
into a domain-specific matrix (analogous to the
topic-specific matrices described by Gentles). Initially,
the matrix consisted of domains for peer review report
quality, followed by items representative of each domain
and references to literature sources that items were ex-
tracted from. As the analysis progressed, subdomains
were created and the final version of the matrix included
domains, subdomains, items and references.
Furthermore, we calculated the proportions of
domains based on the number of items included in each
domain for each tool. According to the proportions
obtained, we created a domain profile for each tool.
Then, we calculated the matrix of Euclidean distances
between the domain profiles. These distances were used
to perform the hierarchical, complete-linkage clustering
analysis, which provided us with a tree structure that we
represent in a chart. Through this graphical summary,
we were able to identify domain similarities among
the different tools, which helped us draw our
Table 2 Examples of definition of scoring system instructions
Scoring system instructions
Defined Partially defined Not defined
5 (Exceptional) = The rare outstanding critique that is
comprehensive, objective, and insightful. Evaluates purpose of
the study, study design, scientific validity, and conclusions by
numbering questions and constructive suggestions to be
addressed by the author. Includes comments to the editor about
whether this is something new and important and useful to our
readers.
4 (Very good) = Excellent review indicating that the paper was
carefully evaluated. Helpful comments to the author and editor
with well-documented reasons for decision.
3 (Good) = Useful type of very satisfactory review. Analysis not as
well organized, documented, or as complete as above but is
reasonable, with adequate comments for the authors.
2 (Below average) = Very brief, superficial evaluation. Reasons for
the decision not explained and comments to authors not helpful.
1 (Unacceptable) = Such a poor review that consideration should
be given to not sending further papers to this reviewer. Reasons
could include evidence of bias, unfair, faulty reasoning, or
evaluation (totally disagrees with the opinion of other reviewers
and editor) and comments to author either absent, inappropriate,
or inadequate to explain how the paper was rated.
(Landkroon 2006) [42]
1 (Poor) = Does not follow reviewer guideline structure or
preferred formatting in providing comments; unfavourable
timeliness.
2 (Acceptable) = Comments are somewhat helpful; review meets
timeline.
3 (Reliable) = Thorough and helpful comments; timely
submission.
4 (Excellent) = Very strong and detailed comments; review was
submitted early or on time; comments enhance the manuscript’s
merit and relevance in the field.
(Rajesh 2013) [32]
1 = poor;
2 = fair;
3 = good;
4 = excellent
(Friedam1995)
[22]
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analytical conclusions. The calculations and graphical
representations were obtained using the statistical
software R 3.3.3 [19].
Results
Study selection and general characteristics of reports
The screening process is summarized in a flow diagram
(Fig.1). Of the 4312 records retrieved, we finally included
46 reports: 39 research articles; 3 editorials; 2 infor-
mation guides; 1 was a letter to the editor and 1 study
was available only as an abstract (excluded studies are
listed in Additional file 2; included studies are listed in
Additional file 3).
General characteristics of the tools
In the 46 reports, we identified 24 tools, including 23
scales and 1 checklist. The tools were developed from
1985 to 2017. Four tools had from 2 to 4 versions [22–25].
Five tools were used as an outcome in a randomized con-
trolled trial [23, 25–28]. Table 3 lists the general character-
istics of the identified tools. Table 4 presents a more
complete descriptive summary of the tools’ characteristics,
including types and measures of validity and reliability.
Six scales consisted of a single item enquiring into the
overall quality of the peer review report, all of them
based on directly asking users to score the overall quality
[22, 25, 29–32]. These tools assessed the quality of a
peer review report by using: 1) a 4 or 5 Likert point scale
(n = 4); 2) as ‘good’, ‘fair’ and ‘poor’ (n = 1); and 3) a re-
stricted scale from 80 to 100 (n = 1). Seventeen scales
and one checklist had several items ranging in number
from 4 to 26. Of these, 10 used the same weight for each
item [23, 24, 27, 28, 33–38]. The overall quality score
was the sum of the score for each item (n = 3); the mean
of the score of the items (n = 6); or the summary score
(n = 11) (for definitions see Table 1). Three scales re-
ported more than one way to assess the overall quality
[23, 24, 36]. The scoring system instructions were not
defined in 67% of the tools.
None of the tools reported the definition of peer
review report quality, and only one described the tool
development [39]. The first version of this tool was
designed by a development group composed of four
researchers and three editors. It was based on a tool
used in an earlier study and that had been developed by
reviewing the literature and interviewing editors. Succes-
sively, the tool was modified by rewording some
Fig. 1 Study selection flow diagram
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questions after some group discussions and a guideline
for using the tool was drawn up.
Only 3 tools assessed and reported a validation
process [39–41]. The assessed types of validity included
face validity, content validity, construct validity, and
preliminary criterion validity. Face and content validity
could involve either a sole editor and author or a group
of researchers and editors. Construct validity was
assessed with multiple regression analysis using dis-
criminant criteria (reviewer characteristics such as age,
sex, and country of residence) and convergent criteria
(training in epidemiology and/or statistics); or the over-
all assessment of the peer review report by authors and
an assessment of (n = 4–8) specific components of the
peer review report by editors or authors. Preliminary
criterion was assessed by comparing grades obtained by
an editor to those obtained by an editor-in-chief using
an earlier version of the tool. Reliability was assessed in
9 tools [24–27, 31, 36, 39, 41, 42]; all reported
inter-rater reliability and 2 also reported test-retest reli-
ability. One tool reported the internal consistency mea-
sured with the Cronbach’s alpha [39].
Quality components of the peer review reports
considered in the tools with more than one item
We extracted 132 items included in the 18 tools. One
item asking for the percentage of co-reviews the re-
viewer had graded was not included in the classification
because it represented a method of measuring
reviewer’s performance and not a component of peer
review report quality.
We organized the key concepts from each item into
‘topic-specific matrices’ (Additional file 4), identifying
nine main domains and 11 subdomains: 1) relevance of
study (n = 9); 2) originality of the study (n = 5); 3) inter-
pretation of study results (n = 6); 4) strengths and weak-
nesses of the study (n = 12) (general, methods and
statistical methods); 5) presentation and organization of
the manuscript (n = 8); 6) structure of the reviewer’s
comments (n = 4); 7) characteristics of reviewer’s com-
ments (n = 14) (clarity, constructiveness, detail/tho-
roughness, fairness, knowledgeability, tone); 8) timeliness
of the review report (n = 7); and 9) usefulness of the
review report (n = 10) (decision making and manuscript
improvement). The total number of tools corresponding
to each domain and subdomain is shown in Fig. 2. An
explanation and example of all domains and subdomains
is provided in Table 5. Some domains and subdomains
were considered in most tools, such as whether the
reviewers’ comments were detailed/thorough (n = 11) and
constructive (n = 9), whether the reviewers’ comments
were on the relevance of the study (n = 9) and if the peer
review report was useful for manuscript improvement
(n = 9). However, other items were rarely considered,
such as whether the reviewer made comments on the
statistical methods (n = 1).
Clustering analysis among tools
We created a domain profile for each tool. For example,
the tool developed by Justice et al. consisted of 5 items
[35]. We classified three items under the domain ‘Cha-
racteristics of the reviewer’s comments’, one under ‘Time-
liness of the review report’ and one under ‘Usefulness of
the review report’. According to the aforementioned clas-
sification, the domain profile (represented by propor-
tions of domains) for this tool was 0.6:0.2:0.2 for the
incorporating domains and 0 for the remaining ones.
The hierarchical clustering used the matrix of Euclidean
distances among domain profiles, which led to five main
clusters (Fig. 3).
The first cluster consisted of 5 tools developed from
1990 to 2016. All tools included at least one item in the
Table 3 Main characteristics of the included tools
Characteristics of tools N (%)
Type of tool:
Scale 23 (96%)
Checklist 1 (4%)
Number of items:
1 6 (25%)
> 1 18 (75%)
Weight of items a:
Same weight 10 (42%)
Different weight 2 (8%)
User defined weight 1 (4%)
Not applicable 11 (46%)a
Score System Instruction:
Defined 5 (21%)
Partially defined 3 (12%)
Not defined 16 (67%)
Tool development:
Reported 1 (4%)
Not reported 23 (96%)
Overall quality assessment b
Single score 6 (22%)
Summary score 11 (41%)
Mean score 6 (22%)
Sum score 3 (11%)
Not reported 1 (4%)
aItem weight is not applicable for scale with a single item (n = 6), checklist (n
= 1) and for scale including more than one item without a numerical score
attached but presenting only a summary score (n = 4)
bThe total number is different because three tools presented more than one
way to assess the overall quality and the checklist did not provide an
overall score
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characteristics of the reviewer’s comments domain, repre-
senting at least 50% of each domain profile. In the
second cluster, there were 3 tools developed from 1994
to 2006. These tools were characterized to incorporate
at least one item in the usefulness and timeliness do-
mains. The third cluster included 6 tools that had been
developed from 1998 to 2010 and exhibited the most
heterogeneous mix of domains. These tools were distinct
from the rest because they encompassed items related to
interpretation of the study results and originality of the
study. Moreover, the third cluster included two tools
with different versions and variations. The first, second,
and third cluster were linked together in the hierarchical
tree that presented tools with at least one quality com-
ponent grouped in the domain characteristics of the
reviewer’s comments. In the fourth cluster, there are 2
tools developed from 2011 to 2017 that consist of at
least one component in the strengths and weaknesses
domain. Finally, the fifth cluster included 2 tools deve-
loped from 2009 to 2012 and which consisted of the
same 2 domains. The fourth and fifth clusters were sepa-
rated from the rest in the hierarchical tree that
presented tools with only a few domains.
Discussion
To the best of our knowledge, this is the first compre-
hensive review that has systematically identified tools
used in biomedical research for assessing the quality of
peer review reports. We have identified 24 tools from
both the medical literature and an internet search: 23
scales and 1 checklist. One out of four tools consisted of
a single item that simply asked the evaluator for a direct
assessment of the peer review report’s ‘overall quality’.
The remaining tools had between 4 to 26 items in which
the overall quality was assessed as the sum of all items,
their mean, or as a summary score.
Since a definition of overall quality was not provided,
these tools consisted exclusively of a subjective quality
assessment by the evaluators. Moreover, we found that
only one study reported a rigorous development process
of the tool, although it included a very limited number
of people. This is of concern because it means that the
identified tools were, in fact, not suitable to assess the
quality of a peer review report, particularly because they
lack a focused theoretical basis. We found 10 tools that
were evaluated for validity and reliability; in particular,
criterion validity was not assessed for any tool.
Fig. 2 Frequency of quality domains and subdomains
Superchi et al. BMC Medical Research Methodology           (2019) 19:48 Page 9 of 14
Table 5 Explanations and Examples of quality domains and subdomains
N Domains Subdomains Explanations and Examples
1 Relevance of the study Explanation: Items inquiring if the reviewer has discussed in the peer review report the
importance of the research question and usefulness of the study.
Example: ‘Did the reviewer give appropriate attention to the importance of the question?’ [28]
2 Originality of the study Explanation: Items inquiring if the reviewer has commented in the peer review report on the
originality of the manuscript.
Example: ‘Did the reviewer discuss the originality of the paper?’ [23, 27]
3 Interpretation of the
study results
Explanation: Items inquiring if the reviewer has commented in the peer review report on how
authors interpreted and discussed the results of the study.
Example: ‘The reviewer commented accurately and productively on the quality of the author’s
interpretation of the data, including acknowledgment of the data’s limitations.’ [26]
4 Strengths and weaknesses
of the study
General Explanation: Items inquiring if the reviewer has identified and commented in the peer review
report on the general strong and weak points of the study.
Example: ‘How well it identified the study’s strengths and weaknesses?’ [35]
Methods Explanation: Items inquiring if the reviewer has identified and commented in the peer review
report on the strong and weak points specifically related to study’s methods
Example: ‘Did the reviewer clearly identify strengths and weaknesses in the study’s
methods?’ [28]
Statistical
methods
Explanation: Items inquiring if the reviewer has identified and commented in the peer review
report on the strong and weak points specifically related to study’s statistical methods
Example: ‘Confidence intervals/p-values/overall fit’ [36]
5 Presentation and organization
of the manuscript
Explanation: Items inquiring if the reviewer has made comments in the peer review report on
the data presentation such as tables and figures and on the organization of the manuscript
such as writing communication.
Example: ‘Are there any constructive suggestions on improvement of a. writing; b. data
presentation and c. interpretation’ [54]
6 Structure of reviewer’s
comments
Explanation: Items inquiring if the reviewer has made in the peer review report organized and
structured comments.
Example: ‘Concise well-organized comments to the editor’ [50]
7 Characteristics of reviewer’s
comments
Clarity Explanation: Items inquiring if the reviewer has provided in the peer review report clear and
easily to read comments.
Example: ‘How clear was this review? The review was easily read and interpreted by the editor
and authors.’ [38]
Constructiveness Explanation: Items inquiring if the reviewer has provided in the peer review report helpful,
relevant and realistic comments.
Example: ‘Were the reviewer’s comments constructive?’ [23, 27]
Detail/
Thoroughness
Explanation: Items inquiring if the reviewer has provided in the peer review report detailed and
thorough comments supplying appropriate evidence.
Example: ‘Detail of commentary’ [33]
Fairness Explanation: Items inquiring if the reviewer has provided in the peer review report balanced
and objective comments.
Example: ‘Balanced/fair’ [24, 36]
Knowledgeability Explanation: Items inquiring if the reviewer has showed in the peer review report to know and
understand correctly the content of the manuscript.
Example: ‘Knowledge of the manuscript’s content area.’ [28]
Tone Explanation: Items inquiring if the reviewer has used a courteous tone in the peer review
report.
Example: ‘Overall tone of the reviewers was also assessed as harsh or courteous.’ [34]
8 Timeliness of the r
eview report
Explanation: Items inquiring if the reviewer has completed the peer review report on time.
Example: ‘Punctuality of the review’ [49]
9 Usefulness of the
review report
Decision making Explanation: Items inquiring if the reviewer has provided a peer review report useful to make a
decision about the acceptance, revision or rejection of a manuscript
Example: ‘The reviewer provided the editor with the proper context and perspective to make
a decision about acceptance or revision of the manuscript.’ [26]
Manuscript
improvement
Explanation: Items inquiring if the reviewer has provided useful suggestions in the peer review
report to improve the manuscript.
Example: ‘This aspect is solely interested in how well the review aids the authors for improving
their work and/or writing. Whether the review makes a good judgment regarding acceptance
of the submission plays no role here whatsoever.’ [53]
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Most of the scales with more than one item resulted
in a summary score. These scales did not consider how
items could be weighted differently. Although commonly
used, scales are controversial tools in assessing quality
primarily because using a score ‘in summarization
weights’ would cause a biased estimation of the mea-
sured object [43]. It is not clear how weights should be
assigned to each item of the scale [18]. Thus different
weightings would produce different scales, which could
provide varying quality assessments of an individual
study [44].
n our methodological systematic review, we found only
one checklist. However, it was neither rigorously devel-
oped nor validated and therefore we could not consider it
adequate for assessing peer review report quality. We be-
lieve that checklists may be a more appropriate means for
assessing quality because they do not present an overall
score, meaning they do not require a weight for the items.
It is necessary to clearly define what the tool mea-
sures. For example, the Risk of Bias (RoB) tool [45]
has a clear aim (to assess trial conduct and not
reporting), and it provides a detailed definition of
each domain in the tool, including support for judg-
ment. Furthermore, it was developed with transparent
procedures, including wide consultation and review of
the empirical evidence. Bias and uncertainty can arise
when using tools that are not evidence-based, rigor-
ously developed, validated and reliable; and this is
particularly true for tools that are used for evaluating
interventions aimed at improving the peer review
process in RCTs, thus affecting how trial results are
interpreted.
We found that most of the items included in the
different tools did not cover the scientific aspects of a
peer review report nor were constrained to biomedical
research. Surprisingly, few tools included an item related
Fig. 3 Hierarchical clustering of tools based on the nine quality domains. The figure shows which quality domains are present in each tool. A
slice of the chart represents a tool, and each slice is divided into sectors, indicating quality domains (in different colours). The area of each sector
corresponds to the proportion of each domain within the tool. For instance, the “Review Rating” tool consists of two domains: Timeliness,
meaning that 25% of all its items are encompassed in this domain, and Characteristics of reviewer’s comments occupying the remaining 75%. The
blue lines starting from the centre of the chart define how the tools are divided into the five clusters. Clusters #1, #2 and #3 are sub-nodes of a
major node grouping all three, meaning that the tools in these clusters have a similar domain profile compared to the tools in clusters #4 and #5
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to the methods used in the study, and only one inquired
about the statistical methods.
In line with a previous study published in 1990 [28],
we believe that the quality components found across all
tools could be further organized according to the
perspective of either an editor or author, specifically by
taking into account the different yet complementary uses
of a peer review report. For instance, reviewer’s com-
ments on the relevance of the study and interpretation of
the study’s results could assist editors in making an
editorial decision, clarity and detail/thoroughness of
reviewer’s comments are important attributes which help
authors improve manuscript quality. We plan to further
investigate the perspectives of biomedical editors and
authors towards the quality of peer review reports by
conducting an international online survey. We will also
include patient editors as survey’s participants as their
involvement in the peer review process can further
ensure that research manuscripts are relevant and
appropriate to end-users [46].
The present study has strengths but also some limita-
tions. Although we implemented a comprehensive
search strategy for reports by following the guidance for
conducting methodological reviews [20], we cannot ex-
clude a possibility that some tools were not identified.
Moreover, we limited the eligibility criteria to reports
published only in English. Finally, although the number
of eligible records we identified through Google® was
very limited, it is possible that we introduced selection
bias due to a (re)search bubble effect [47].
Due to the lack of a standard definition of quality, a
variety of tools exist for assessing the quality of a peer
review report. Overall, we were able to establish 9 qua-
lity domains. Between two to seven domains were used
among each of the 18 tools. The variety of items and
item combinations amongst tools raises concern about
variations in the quality of publications across bio-
medical journals. Low-quality biomedical research im-
plies a tremendous waste of resources [48] and explicitly
affects patients’ lives. We strongly believe that a vali-
dated tool is necessary for providing a clear definition of
peer review report quality in order to evaluate interven-
tions aimed at improving the peer review process in
well-performed trials.
Conclusions
The findings from this methodological systematic review
show that the tools for assessing the quality of a peer re-
view report have various components, which have been
grouped into 9 domains. We plan to survey a sample of
editors and authors in order to refine our preliminary
classifications. The results from further investigations
will allow us to develop a new tool for assessing the
quality of peer review reports. This in turn could be
used to evaluate interventions aimed at improving the
peer review process in RCTs. Furthermore, it would help
editors: 1) evaluate the work of reviewers; 2) provide
specific feedback to reviewers; and 3) identify reviewers
who provide outstanding review reports. Finally, it might
be further used to score the quality of peer review
reports in developing programs to train new reviewers.
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